-
Clinical Trials & Development1 week agoResearchers Validate Buoyant Mass for Cell Health Testing
Scientists have used measurement of buoyant mass by suspended microchannel resonator (SMR) technology to assess the immune fitness of T cells and predict patient response to...
-
Clinical Trials & Development1 week agoDrug prices climb past $250K as US patients balk at the pharmacy
Just one-third of patients prescribed new medicines filled them within 30 days, with a new report from the Institute for Clinical and Economic Review and West...
-
Clinical Trials & Development1 week agoDisc’s redemption, China’s rise, Veradermics’ validation, ESMO’s headliners
China cracks down on some biotechnology ownership transfers—but will the new policy impact licensing deals?; Disc Medicine’s Phase 3 data sweep redeems rejected rare disease therapy,...
-
Clinical Trials & Development1 week agoNovo’s CagriSema achieves 25% weight loss in women, driven by younger patients
Posthoc analyses in women divided by menopausal status show how Novo’s next-generation GLP-1 drug affects key cohorts of patients.
-
Clinical Trials & Development1 week agoCagriSema helps women lose 25% of their weight in study
Novo continues to build the case for its new weight-loss candidate CagriSema, pointing to new data that show strong efficacy in women.
-
Clinical Trials & Development1 week agoSTAT+: A German biotech has big ambitions in cancer. Now it needs to get a medicine approved
After a quarter century of work, the German biotech Immatics is facing a pivotal moment as it awaits Phase 3 results for its lead candidate in...
-
Clinical Trials & Development1 week agoSubmitting Clinical Trial Data to Evaluate the Ability to Operate a Motor Vehicle
Guidance for Industry: Technical Specifications Document, Submitting Clinical Trial Data to Evaluate the Ability to Operate a Motor Vehicle
-
Clinical Trials & Development1 week agoGilead’s ‘highly competitive’ mid-stage ulcerative colitis data ‘validate’ I&I push
Gilead’s emvistegrast delivered greater clinical response than placebo, setting up the asset for Phase 3 testing in ulcerative colitis as well as studies in other inflammatory...
-
Clinical Trials & Development1 week agoAZ and Oracle team up on AI platform for clinical trials
AstraZeneca has launched a project with tech giant Oracle that will use AI and real-world data to improve clinical research and patient care.
-
Clinical Trials & Development1 week agoDisc’s Phase III win addresses FDA’s concerns about bitopertin’s efficacy
BIOCENTURY | PRODUCT DEVELOPMENTDISC’S PHASE III WIN ADDRESSES FDA’S CONCERNS ABOUT BITOPERTIN’S EFFICACY BioCentury’s Clinical Report, October 13-19
LncRNA SBF2-AS1 Worsens Heart Injury After Attack via miR-149-5p/PHLPP2 Axis
Stigmatizing language found in over half of primary care patient records
Research report: The Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Iclepertin (BI 425809): Results from Two Phase I Open-Label, Non-randomised, Single Dose, Parallel Design Studies
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
